Precise targeting and controlled drug release can significantly enhance the therapeutic efficacy of cancer treatment. Trackable smart drug delivery systems have gained attention in the past decade because they can
Over the past decade, oncology research has ushered in tremendous advances in the understanding of genes that can mutate and cause cancer. But what, exactly, is going awry with those
Over 18,000 leaders in Biotech and Pharma attended the 2018 BIO convention. This year the Avacta team will be exhibiting and will be found on booth 3559. Further information about
In a recent article over at genengnews.com Sue Pearson discusses ‘Antibody Mimetics – More effective treatments for solid tumors?’ and the use of Avacta Group plc (LON:AVCT) Affirmers. Alastair Smith, Chief
“The sad fact is that around 70% of cancer patients with solid based tumors don’t respond to classical chemotherapy,” said Joseph Tabernero, MD, PhD, head of Val d’Hebron Institute of
Avacta Group’s Alastair Smith discusses the development partnership and license agreement with LG Chem, in-house drug development and the collaborations with Moderna & Tufts in this exclusive interview with DirectorsTalk
Avacta Group (LON: AVCT) CEO Alastair Smith joins DirectorsTalk to discuss interim results for the period ended 31st Jan 2019. Alastair talks us through the LG Chem deal, shares his thoughts
I invited you to suggest smaller companies that are ‘potential world-beaters’ for the next layer of stocks in our UK Optimist Fund portfolio and your wide-ranging responses gave rise to
Attending WRIB next week? The Avacta team are, and will be found on booth 61. A Week of Bioanalysis, Biomarkers, and Immunogenecity at WRIB Avacta Group Plc (LON:AVCT) principal focus
Avacta has been listed in Business Weekly’s “The Killer 50: Ones2Watch” Avacta Group Plc (LON:AVCT) principal focus is on its proprietary Affimer® technology which is a novel engineered alternative to
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
